-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
-
Summary
-
INTEGRATED BIOPHARMA INC quarterly/annual Net Cash Provided by (Used in) Financing Activities history and change rate from Q3 2010 to Q3 2025.
- INTEGRATED BIOPHARMA INC Net Cash Provided by (Used in) Financing Activities for the quarter ending 30 Sep 2025 was -$11K, a 57.1% decline year-over-year.
- INTEGRATED BIOPHARMA INC annual Net Cash Provided by (Used in) Financing Activities for 2025 was $78K.
- INTEGRATED BIOPHARMA INC annual Net Cash Provided by (Used in) Financing Activities for 2024 was -$29K, a 78.7% increase from 2023.
- INTEGRATED BIOPHARMA INC annual Net Cash Provided by (Used in) Financing Activities for 2023 was -$136K, a 96.1% increase from 2022.
Net Cash Provided by (Used in) Financing Activities, Quarterly (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Quarterly Change (%)
Net Cash Provided by (Used in) Financing Activities, Annual (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Annual Change (%)